365 related articles for article (PubMed ID: 25192975)
41. Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection.
Li K; Li Z; Wohlford-Lenane C; Meyerholz DK; Channappanavar R; An D; Perlman S; McCray PB; He B
mBio; 2020 Apr; 11(2):. PubMed ID: 32265331
[TBL] [Abstract][Full Text] [Related]
42. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study.
Reusken CB; Haagmans BL; Müller MA; Gutierrez C; Godeke GJ; Meyer B; Muth D; Raj VS; Smits-De Vries L; Corman VM; Drexler JF; Smits SL; El Tahir YE; De Sousa R; van Beek J; Nowotny N; van Maanen K; Hidalgo-Hermoso E; Bosch BJ; Rottier P; Osterhaus A; Gortázar-Schmidt C; Drosten C; Koopmans MP
Lancet Infect Dis; 2013 Oct; 13(10):859-66. PubMed ID: 23933067
[TBL] [Abstract][Full Text] [Related]
43. DNA vaccine prime and replicating vaccinia vaccine boost induce robust humoral and cellular immune responses against MERS-CoV in mice.
Shen X; Wang S; Hao Y; Fu Y; Ren L; Li D; Tang W; Li J; Chen R; Zhu M; Wang S; Liu Y; Shao Y
Virol Sin; 2024 Jun; 39(3):490-500. PubMed ID: 38768713
[TBL] [Abstract][Full Text] [Related]
44. Prospects for a MERS-CoV spike vaccine.
Zhou Y; Jiang S; Du L
Expert Rev Vaccines; 2018 Aug; 17(8):677-686. PubMed ID: 30058403
[TBL] [Abstract][Full Text] [Related]
45. Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels.
Alharbi NK; Qasim I; Almasoud A; Aljami HA; Alenazi MW; Alhafufi A; Aldibasi OS; Hashem AM; Kasem S; Albrahim R; Aldubaib M; Almansour A; Temperton NJ; Kupke A; Becker S; Abu-Obaidah A; Alkarar A; Yoon IK; Azhar E; Lambe T; Bayoumi F; Aldowerij A; Ibrahim OH; Gilbert SC; Balkhy HH
Sci Rep; 2019 Nov; 9(1):16292. PubMed ID: 31705137
[TBL] [Abstract][Full Text] [Related]
46. Development of a recombinant vaccine containing a spike S1-Fc fusion protein induced protection against MERS-CoV in human DPP4 knockin transgenic mice.
Jung BK; An Y; Park JE; Chang KS; Jang H
J Virol Methods; 2022 Jan; 299():114347. PubMed ID: 34728273
[TBL] [Abstract][Full Text] [Related]
47. Intranasal immunization with a Middle East respiratory syndrome-coronavirus antigen conjugated to the M-cell targeting ligand Co4B enhances antigen-specific mucosal and systemic immunity and protects against infection.
Yang YL; Kim J; Jeong Y; Jang YS
Vaccine; 2022 Jan; 40(5):714-725. PubMed ID: 34991928
[TBL] [Abstract][Full Text] [Related]
48. High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.
Alshukairi AN; Zheng J; Zhao J; Nehdi A; Baharoon SA; Layqah L; Bokhari A; Al Johani SM; Samman N; Boudjelal M; Ten Eyck P; Al-Mozaini MA; Zhao J; Perlman S; Alagaili AN
mBio; 2018 Oct; 9(5):. PubMed ID: 30377284
[TBL] [Abstract][Full Text] [Related]
49. Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.
Tang J; Zhang N; Tao X; Zhao G; Guo Y; Tseng CT; Jiang S; Du L; Zhou Y
Hum Vaccin Immunother; 2015; 11(5):1244-50. PubMed ID: 25874632
[TBL] [Abstract][Full Text] [Related]
50. Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.
Wang Y; Tai W; Yang J; Zhao G; Sun S; Tseng CK; Jiang S; Zhou Y; Du L; Gao J
Hum Vaccin Immunother; 2017 Jul; 13(7):1615-1624. PubMed ID: 28277821
[TBL] [Abstract][Full Text] [Related]
51. A Novel Bacterium-Like Particle Vaccine Displaying the MERS-CoV Receptor-Binding Domain Induces Specific Mucosal and Systemic Immune Responses in Mice.
Li E; Chi H; Huang P; Yan F; Zhang Y; Liu C; Wang Z; Li G; Zhang S; Mo R; Jin H; Wang H; Feng N; Wang J; Bi Y; Wang T; Sun W; Gao Y; Zhao Y; Yang S; Xia X
Viruses; 2019 Aug; 11(9):. PubMed ID: 31470645
[TBL] [Abstract][Full Text] [Related]
52. Antibodies and vaccines against Middle East respiratory syndrome coronavirus.
Xu J; Jia W; Wang P; Zhang S; Shi X; Wang X; Zhang L
Emerg Microbes Infect; 2019; 8(1):841-856. PubMed ID: 31169078
[TBL] [Abstract][Full Text] [Related]
53. Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines.
Du L; Tai W; Yang Y; Zhao G; Zhu Q; Sun S; Liu C; Tao X; Tseng CK; Perlman S; Jiang S; Zhou Y; Li F
Nat Commun; 2016 Nov; 7():13473. PubMed ID: 27874853
[TBL] [Abstract][Full Text] [Related]
54. Stabilized coronavirus spike stem elicits a broadly protective antibody.
Hsieh CL; Werner AP; Leist SR; Stevens LJ; Falconer E; Goldsmith JA; Chou CW; Abiona OM; West A; Westendorf K; Muthuraman K; Fritch EJ; Dinnon KH; Schäfer A; Denison MR; Chappell JD; Baric RS; Graham BS; Corbett KS; McLellan JS
Cell Rep; 2021 Nov; 37(5):109929. PubMed ID: 34710354
[TBL] [Abstract][Full Text] [Related]
55. A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines.
Du L; Kou Z; Ma C; Tao X; Wang L; Zhao G; Chen Y; Yu F; Tseng CT; Zhou Y; Jiang S
PLoS One; 2013; 8(12):e81587. PubMed ID: 24324708
[TBL] [Abstract][Full Text] [Related]
56. Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice.
Coleman CM; Liu YV; Mu H; Taylor JK; Massare M; Flyer DC; Smith GE; Frieman MB
Vaccine; 2014 May; 32(26):3169-3174. PubMed ID: 24736006
[TBL] [Abstract][Full Text] [Related]
57. Genomic Sequencing and Analysis of Eight Camel-Derived Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Isolates in Saudi Arabia.
Al-Shomrani BM; Manee MM; Alharbi SN; Altammami MA; Alshehri MA; Nassar MS; Bakhrebah MA; Al-Fageeh MB
Viruses; 2020 Jun; 12(6):. PubMed ID: 32503352
[TBL] [Abstract][Full Text] [Related]
58. MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection.
Tai W; Zheng J; Zhang X; Shi J; Wang G; Guan X; Zhu J; Perlman S; Du L
Virus Res; 2023 Sep; 334():199156. PubMed ID: 37336390
[TBL] [Abstract][Full Text] [Related]
59. MERS Vaccine Candidate Offers Promise, but Questions Remain.
Menachery VD
EBioMedicine; 2015 Oct; 2(10):1292-3. PubMed ID: 26629514
[No Abstract] [Full Text] [Related]
60. Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia.
Kasem S; Qasim I; Al-Hufofi A; Hashim O; Alkarar A; Abu-Obeida A; Gaafer A; Elfadil A; Zaki A; Al-Romaihi A; Babekr N; El-Harby N; Hussien R; Al-Sahaf A; Al-Doweriej A; Bayoumi F; Poon LLM; Chu DKW; Peiris M; Perera RAPM
J Infect Public Health; 2018; 11(3):331-338. PubMed ID: 28993171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
